donepezil has been researched along with Abnormal Movements in 1 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our aim was to examine if donepezil administered to stable, medicated outpatients with schizophrenia improves cognition and psychopathology." | 9.11 | Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. ( Cather, C; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Herz, L, 2005) |
| "Our aim was to examine if donepezil administered to stable, medicated outpatients with schizophrenia improves cognition and psychopathology." | 5.11 | Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. ( Cather, C; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Herz, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freudenreich, O | 1 |
| Herz, L | 1 |
| Deckersbach, T | 1 |
| Evins, AE | 1 |
| Henderson, DC | 1 |
| Cather, C | 1 |
| Goff, DC | 1 |
1 trial available for donepezil and Abnormal Movements
| Article | Year |
|---|---|
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial.
Topics: Capsules; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Dose-Response Relationship, Dru | 2005 |